Merck, S1764-1ML, Complement sera human

General description
Complement serum is prepared from pooled human plasma and lyophilized from the amount of serum indicated on the label.
Application
Complement sera human has been used:
to incubate DLD-1 or SW-620 cells to quantify C5a release
in multiplex bead antibody-binding assay to assay C3d
in complement-dependent cytotoxicity assay

Complement sera human has been used:
to incubate DLD-1 or SW-620 cells to quantify C5a release
in multiplex bead antibody-binding assay to assay C3d
in complement-dependent cytotoxicity assay

The activity of complement sera can be determined by hemolytic assays in vitro.
Physical form
Lyophilized powder from indicated amount of serum
Analysis Note
Hemolytic titer (CH50 units per ml) is determined by method of Kabat and Mayer. Actual titer given on label.
Disclaimer
RESEARCH USE ONLY. This product is regulated in France when intended to be used for scientific purposes, including for import and export activities (Article L 1211-1 paragraph 2 of the Public Health Code). The purchaser (i.e. enduser) is required to obtain an import authorization from the France Ministry of Research referred in the Article L1245-5-1 II. of Public Health Code. By ordering this product, you are confirming that you have obtained the proper import authorization.